Natalie Nairn

Company: Cyclera Therapeutics

Job title: Cofounder and CEO

Seminars:

CYpHER: Catalytic Extracellular TPD for Potent Durable Effect in Oncology & CNS Disease 9:00 am

Engineering bispecific proteins that utilize transferrin receptor and pH-sensitive target binding to direct disease-driving proteins to the endolysosomal system Catalytic activity provides high potency and durability PD activity across mutational settings with superior activity and targeting versus traditional modalitiesRead more

day: Post-Conference Focus Day